OverviewChartNewsTraderScreen

UC DIS.CERT. 09/24 BRM/  DE000HD1NM69  /

gettex
6/17/2024  1:45:57 PM Chg.-0.100 Bid6/17/2024 Ask6/17/2024 Underlying Strike price Expiration date Option type
37.970EUR -0.26% 37.970
Bid Size: 500		 37.990
Ask Size: 500		 BRISTOL-MYERS SQUIBB... - - 9/27/2024 Call
GlobeNewswire 1:00 PM Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angel...
GlobeNewswire 6/14 Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire 6/12 Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
GlobeNewswire 6/11 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
GlobeNewswire 6/11 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 6/11 Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
GlobeNewswire 6/10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 6/10 C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
GlobeNewswire 5/31 Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire 5/30 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 5/24 Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
GlobeNewswire 5/23 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 5/23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire 5/22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 5/22 Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 5/16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 5/15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 5/14 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...
GlobeNewswire 5/14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 5/13 Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Immunocore reports first quarter financial results and provides a business update
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/2 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...
GlobeNewswire 5/1 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration